Trial of chloroquine to treat COVID-19 stopped early due to heart complications [FOX News]
New York Times Company (The) (NYT)
Last new york times company (the) earnings: 2/6 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.nytco.com/investors/default.aspx
Company Research
Source: FOX News
A bottle of hydroxychloroquine is displayed on a table outside The Resort at Texas City nursing home Tuesday, April 7, 2020, in Texas City, Texas. (AP Photo/David J. Phillip)A Brazilian study testing theantimalarial drug chloroquine for COVID-19heart rhythm problemsChloroquine and the related drug hydroxychloroquine have made headlines in recent weeks after President Donald Trump called the drugs a potential "game changer" for the treatment of COVID-19.The Brazilian researchers planned to enroll 440 people in their study to test whether chloroquine is a safe and effective treatment for COVID-19. Participants took either a "high dose" of the drug (600 milligrams twice daily for 10 days) or a "low dose" (450 mg for five days, with a double dose only on the first day). The study was "double blind," meaning that neither the patients nor their doctors knew which dose they were receiving.However, after enrolling just 81 patients, the researchers saw some concerning signs. Within a few days
Show less
Read more
Impact Snapshot
Event Time:
NYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYT alerts
High impacting New York Times Company (The) news events
Weekly update
A roundup of the hottest topics
NYT
News
- Another line of attack: White House sets up a hall of shame for news outlets [Los Angeles Times (CA)]Los Angeles Times
- Another line of attack: White House sets up a hall of shame for news outlets [Yahoo! Finance Canada]Yahoo! Finance Canada
- Erika Kirk speaks at New York Times DealBook Summit [FOX News]FOX News
- Why The New York Times Company Stock Gained 13% in November [Yahoo! Finance]Yahoo! Finance
- Bald eagle thought to be shot in Massachusetts was actually injured in eagle fight, vets believe [CBS News]CBS News
NYT
Earnings
- 11/5/25 - Beat
NYT
Sec Filings
- 11/10/25 - Form 4
- 11/6/25 - Form 144
- 11/5/25 - Form 10-Q
- NYT's page on the SEC website